Literature DB >> 32936424

Molecular characteristics associated with ferroptosis in hepatocellular carcinoma progression.

Zuo Fei1, Yin Lijuan2, Zhuang Jing3, Yang Xi4, Pan Yuefen4, Han Shuwen5.   

Abstract

The aim of this study was to investigate the genes associated with ferroptosis and the progression of hepatocellular carcinoma (HCC). The RNA sequencing data of erastin-induced ferroptosis in HCC cells were downloaded from the Sequence Read Archive database with accession number SRP119173. The microarray dataset GSE89377 of HCC progression was downloaded from the Gene Expression Omnibus database. The ferroptosis-related genes were screened by differential analysis and HCC progression-related genes were screened by cluster analysis using Mfuzz. Then, the genes associated with ferroptosis and HCC progression were screened by Venn analysis, followed by functional enrichment, protein-protein interaction (PPI) analysis, and transcription factor (TF) prediction. Finally, survival analysis was performed using data from the Cancer Genome Atlas database. A total of 33 upregulated and 52 downregulated genes associated with HCC progression and ferroptosis were obtained, and these genes were significantly involved in the negative regulation of ERK1 and ERK2 cascades; the NAD biosynthetic process; alanine, aspartate, and glutamate metabolism; and other pathways. The PPI network contained 52 genes and 78 interactions, of which, cell division cycle 20 (CDC20) and heat shock protein family B (small) member 1 (HSPB1) were hub genes found in higher degrees. Among the 85 genes associated with HCC progression and ferroptosis, two TFs (activating TF 3 (ATF3) and HLF) were predicted, with HSPB1 targeted by ATF3. In addition, 26 genes that were found to be significantly correlated with the overall survival of HCC patients were screened, including CDC20 and thyroid hormone receptor interactor 13. Several genes associated with HCC progression and ferroptosis were screened based on a comprehensive bioinformatics analysis. These genes played roles in HCC progression and ferroptosis via the negative regulation of the ERK1 and ERK2 cascades; the NAD biosynthetic process; and alanine, aspartate, and glutamate metabolism. ATF3 and HSPB1 played important roles in HCC progression and ferroptosis, with HSPB1 possibly regulated by ATF3.

Entities:  

Keywords:  Activating transcription factor 3; Ferroptosis; Heat shock protein family B member 1; Hepatocellular carcinoma; Overall survival

Mesh:

Substances:

Year:  2020        PMID: 32936424     DOI: 10.1007/s13577-020-00431-w

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  36 in total

1.  Sorafenib induces ferroptosis in human cancer cell lines originating from different solid tumors.

Authors:  Emma Lachaier; Christophe Louandre; Corinne Godin; Zuzana Saidak; Maxime Baert; Momar Diouf; Bruno Chauffert; Antoine Galmiche
Journal:  Anticancer Res       Date:  2014-11       Impact factor: 2.480

Review 2.  Hepatocellular Carcinoma.

Authors:  Augusto Villanueva
Journal:  N Engl J Med       Date:  2019-04-11       Impact factor: 91.245

Review 3.  Targeting Ferroptosis to Iron Out Cancer.

Authors:  Behrouz Hassannia; Peter Vandenabeele; Tom Vanden Berghe
Journal:  Cancer Cell       Date:  2019-05-16       Impact factor: 31.743

Review 4.  Emerging Strategies of Cancer Therapy Based on Ferroptosis.

Authors:  Zheyu Shen; Jibin Song; Bryant C Yung; Zijian Zhou; Aiguo Wu; Xiaoyuan Chen
Journal:  Adv Mater       Date:  2018-01-22       Impact factor: 30.849

5.  Ferroptosis: an iron-dependent form of nonapoptotic cell death.

Authors:  Scott J Dixon; Kathryn M Lemberg; Michael R Lamprecht; Rachid Skouta; Eleina M Zaitsev; Caroline E Gleason; Darpan N Patel; Andras J Bauer; Alexandra M Cantley; Wan Seok Yang; Barclay Morrison; Brent R Stockwell
Journal:  Cell       Date:  2012-05-25       Impact factor: 41.582

Review 6.  Recent Progress in Ferroptosis Inducers for Cancer Therapy.

Authors:  Chen Liang; Xinglin Zhang; Mengsu Yang; Xiaochen Dong
Journal:  Adv Mater       Date:  2019-10-08       Impact factor: 30.849

Review 7.  Ferroptosis: process and function.

Authors:  Y Xie; W Hou; X Song; Y Yu; J Huang; X Sun; R Kang; D Tang
Journal:  Cell Death Differ       Date:  2016-01-22       Impact factor: 15.828

Review 8.  Hepatocellular carcinoma: From diagnosis to treatment.

Authors:  Miral Sadaria Grandhi; Amy K Kim; Sean M Ronnekleiv-Kelly; Ihab R Kamel; Mounes A Ghasebeh; Timothy M Pawlik
Journal:  Surg Oncol       Date:  2016-03-05       Impact factor: 3.279

Review 9.  Sorafenib: A Review in Hepatocellular Carcinoma.

Authors:  Gillian M Keating
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.864

Review 10.  Ferroptosis, a new form of cell death, and its relationships with tumourous diseases.

Authors:  Haitao Yu; Pengyi Guo; Xiaozai Xie; Yi Wang; Gang Chen
Journal:  J Cell Mol Med       Date:  2016-11-10       Impact factor: 5.310

View more
  9 in total

Review 1.  The Critical Role of Ferroptosis in Hepatocellular Carcinoma.

Authors:  Fan Pan; Xinrong Lin; Liping Hao; Ting Wang; Haizhu Song; Rui Wang
Journal:  Front Cell Dev Biol       Date:  2022-06-21

2.  The Value of Emergency Nursing Mode in the Treatment of Patients with Traumatic Shock.

Authors:  Jinmei Xu; Xueying Zhou; Chunying Wang; Jianli Hu
Journal:  J Healthc Eng       Date:  2022-01-06       Impact factor: 2.682

3.  Down-Regulation of Activating Transcription Factor 3 (ATF3) in Hepatoblastoma and Its Relationship with Ferroptosis.

Authors:  Jing-Xiao Li; Jin-Shu Pang; Bin-Tong Yin; Gang Chen; Jun-Hong Chen; Jia-Yuan Luo; Xia Yang; Li-Ting Qin; Jiang-Hui Zeng; Peng Chen; Jia-Bo Chen; Deng Tang
Journal:  Int J Gen Med       Date:  2021-12-06

4.  Heat Shock Protein Beta 1 is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma.

Authors:  Shengyi Long; Fang Peng; Baohui Song; Liang Wang; Jun Chen; Bingbing Shang
Journal:  Int J Gen Med       Date:  2021-09-10

5.  Genetic analysis of potential biomarkers and therapeutic targets in ferroptosis from coronary artery disease.

Authors:  Xun Wu; Kele Qin; Chukwuemeka Daniel Iroegbu; Kun Xiang; Jun Peng; Jianjun Guo; Jinfu Yang; Chengming Fan
Journal:  J Cell Mol Med       Date:  2022-02-13       Impact factor: 5.310

6.  Network Pharmacology Identifies Therapeutic Targets and the Mechanisms of Glutathione Action in Ferroptosis Occurring in Oral Cancer.

Authors:  Chen Huang; Lei Zhan
Journal:  Front Pharmacol       Date:  2022-03-14       Impact factor: 5.810

7.  Macrophage Subsets and Death Are Responsible for Atherosclerotic Plaque Formation.

Authors:  Hongxia Li; Zhiqiang Cao; Lili Wang; Chang Liu; Hongkun Lin; Yuhan Tang; Ping Yao
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

8.  A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.

Authors:  Yuliang Wang; Jiaqi Fan; Tao Chen; Lele Xu; Pengyu Liu; Lijia Xiao; Tao Wu; Qingchun Zhou; Qingyou Zheng; Chunxiao Liu; Franky Leung Chan; Dinglan Wu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-10       Impact factor: 6.055

9.  Identification of the Novel Gene Markers Based on the Gene Profile among Different Severity of Obstructive Sleep Apnea.

Authors:  Yi Ren; Yanyan Li; Xuemei Sui; Jinhe Yuan; Jun Lan; Xiayu Li; Yue Deng; Zhiping Xu; Xiu Cheng; Changjing Zhao; Junyu Lu
Journal:  Comput Math Methods Med       Date:  2022-10-04       Impact factor: 2.809

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.